10160-28-8

Basic information

• Product Name: 8-NONYN-1-OL
• Synonyms: 8-NONYN-1-OL
• CAS NO: 10160-28-8
• Molecular Formula: C₉H₁₆O
• Molecular Weight: 140.22
• Mol File: 10160-28-8.mol
• Article Data: 51

Chemical Properties

• Melting Point: -16°C (estimate)
• Boiling Point: 226.76°C (rough estimate)
• Flash Point: 144.6°C
• Appearance: /
• Density: 0.8565 (estimate)
• Vapor Pressure: 0.0392mmHg at 25°C
• Refractive Index: 1.4415 (estimate)
• Storage Temp.: 2-8°C
• PKA: 15.19±0.10(Predicted)
• CAS DataBase Reference: 8-NONYN-1-OL(CAS DataBase Reference)
• NIST Chemistry Reference: 8-NONYN-1-OL(10160-28-8)
• EPA Substance Registry System: 8-NONYN-1-OL(10160-28-8)

Safety Data

• Hazardous Substances Data: 10160-28-8(Hazardous Substances Data)

Usage

General Description

8-Nonyn-1-ol is a chemical compound with the molecular formula C9H18O. It is a linear, unsaturated alcohol with a nonyl (C9H19) chain and a hydroxyl group (-OH) attached to the first carbon atom. 8-Nonyn-1-ol is a colorless liquid with a faint odor and is insoluble in water but soluble in organic solvents. 8-Nonyn-1-ol is commonly used as a surfactant and emulsifier in industrial and household products, as well as a precursor in the synthesis of fragrances and flavorings. It is also utilized in the production of lubricants, plasticizers, and other chemical intermediates. 8-Nonyn-1-ol is flammable and should be handled with caution.

InChI:InChI=1/C9H16O/c1-2-3-4-5-6-7-8-9-10/h1,10H,3-9H2

Upstream product

• 10160-26-6 9-(2-tetrahydropyranyloxy)-1-nonyne 
• 31333-13-8 3-nonyn-1-ol 
• 5921-73-3 2-nonyn-1-ol 
• 90675-38-0 non-8-ynoic acid chloride 
• 49826-98-4 Non-4-yn-1-ol 
• 30964-01-3 non-8-ynoic acid 
• 7003-48-7 non-8-ynoic acid methyl ester 
• 132381-22-7 2-(1-Benzenesulfinyl-pentyl)-tetrahydro-furan 
• 55944-70-2 7-chloro-1-heptanol 
• 70277-75-7 lithium acetylide 
• 10160-24-4 7-bromoheptyl alcohol 
• 1216963-74-4 lithium acetylide-ethylenediamine complex 
• 34683-71-1 undec-2-yn-1-ol 
• 821-57-8 7-chloroheptanoic acid 

Downstream Products

• 87462-64-4 non-8-ynyl 4-methylbenzenesulfonate 
• 95303-88-1 9-hydroxy-2-phenylsulphinylnon-1-ene 
• 13038-21-6 non-8-en-1-ol 
• 519039-32-8 tert-butyl(non-8-yn-1-yloxy)diphenylsilane 
• 866885-79-2 (5R)-3-(9-iodonon-8-enyl)-5-methyl-3-(phenylsulfanyl)tetrahydrofuran-2-one 
• 866885-84-9 (5R)-3-[(S)-14-hydroxy-14-((S)-5-oxotetrahydrofuran-2-yl)tetradec-8-en-10-ynyl]-5-methyl-3-(phenylsulfanyl)dihydrofuran-2-one 
• 866885-88-3 (5R)-3-[(S)-14-hydroxy-14-((S)-5-oxotetrahydrofuran-2-yl)tetradecyl]-5-methyl-3-(phenylsulfanyl)dihydrofuran-2-one 
• 628692-80-8 tert-butyl-(11-nonyloxy-undec-8-ynyloxy)-diphenyl-silane 
• 478404-31-8 8,10-octadecadiyne-1,18-diyl bis-N-phenylcarbamate 

Relevant articles and documents

Streamlined One-Pot Synthesis of Nitro Fatty Acids

A novel method for the synthesis of nitro fatty acids (NFAs), an intriguing class of endogenously occurring lipid mediators, is reported. This one-pot procedure enables the controlled and stereoselective construction of nitro fatty acids from a simple set of common building blocks in a highly facile manner. Thereby, this methodology offers a streamlined, highly modular access to naturally occurring nitro fatty acids as well as non-natural NFA derivatives.

Enantioselective Rhodium-Catalyzed Dimerization of ω-Allenyl Carboxylic Acids: Straightforward Synthesis of C2-Symmetric Macrodiolides

Herein, we report on the first enantioselective and atom-efficient catalytic one-step dimerization method to selectively transform ω-allenyl carboxylic acids into C2-symmetric 14- to 28-membered bismacrolactones (macrodiolides). This convenient asymmetric access serves as an attractive route towards multiple naturally occuring homodimeric macrocyclic scaffolds and demonstrates excellent efficiency to construct the complex, symmetric core structures. By utilizing a rhodium catalyst with a modified chiral cyclopentylidene-diop ligand, the desired diolides were obtained in good to high yields, high diastereoselectivity, and excellent enantioselectivity.

20-HETE RECEPTOR (GPR75) ANTAGONISTS AND METHODS OF USE

The present invention concerns compounds and their use to treat cardiovascular disease, renal disease, thrombic disease, stroke, metabolic syndrome, cell proliferation, and ischemic cardiovascular disorders. Compounds of the present invention display sign